目錄:MedChemExpress LLC>>信號(hào)通路>> Tipifarnib | 替吡法尼 | MedChemExpress (MCE)
參考價(jià) | ¥ 1292 |
參考價(jià) | ¥ 1292 |
更新時(shí)間:2024-01-10 11:23:35瀏覽次數(shù):141評(píng)價(jià)
聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息,謝謝!
CAS | 192185-72-1 | 純度 | 99.89% |
---|---|---|---|
分子量 | 489.4 | 分子式 | C??H??Cl?N?O |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 10 mM * 1 mL |
貨號(hào) | HY-10502 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。
CAS No. : 192185-72-1
MCE 國際站:Tipifarnib
產(chǎn)品活性:Tipifarnib (IND 58359) 抑制法尼基轉(zhuǎn)移酶 (FTase),IC50 為 0.86 nM。Tipifarnib 具有潛在抗腫瘤和抗寄生蟲活性。
研究領(lǐng)域:Metabolic Enzyme/Protease
作用靶點(diǎn):Farnesyl Transferase
In Vitro: Tipifarnib is a potent inhibitor of Trypanosoma Cruzi with the ED50 of 4 nM.
Tipifarnib inhibits isolated human farnesyltransferase for a lamin B peptide and for the K-RasB peptide with IC50 of 0.86 nM and 7.9 nM, respectively.
Tipifarnib shows inhibition of cell growth or angiogenesis, and induction of apoptosis in aggressive prostate cancer (PCa).
Tipifarnib (0.25 μM, 1?μM; 48 h) shows a significant decrease in the concentration of exosomes in C4-2B cells and PC-3 cells.
Tipifarnib (1?μM) significantly inhibits the protein concentration of Alix, nSMase2, and Rab27a in C4-2B cells.
Tipifarnib (0.25 μM) significantly inhibits the activation of p-ERK (downstream effector molecule of the Ras/Raf/ERK signaling pathway) but not total ERK in C4-2B and PC-3 cells.
Tipifarnib (1.25-5 μM; 30 min) promotes endoplasmic reticulum stress in U937 cells, resulting in dysregulation of intracellular calcium homeostasis.
In Vivo: Tipifarnib (10 mg/kg; ip; single dose) upregulated antiapoptotic protein, Bcl-xL in liver, and prevents mosue death induced by GalN/LPS.
相關(guān)產(chǎn)品:Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Anti-Infection Compound Library | Metabolism/Protease Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Drug Repurposing Compound Library | Endoplasmic Reticulum Stress Compound Library | FDA Approved & Pharmacopeial Drug Library | Exosomes Compound Library | Anti-Pancreatic Cancer Compound Library | Antiparasitic Compound library | Targeted Diversity Library | Rare Diseases Drug Library | Anti-Prostate Cancer Compound Library | Non-steroidal Anti-Inflammatory Compound Library | Lonafarnib | L-778123 hydrochloride | FTI-277 hydrochloride | CP-609754 | Arglabin | FGTI-2734 | Manumycin A | BMS-214662 | YM-53601 | FTI 276 TFA | ABT-100 | FTI-2153 | LB42708 | Tipifarnib (S enantiomer) | Andrastin A | Antifungal agent 46 | Ftase inhibitor I | Ftase inhibitor III | FTase-IN-1 | FTI-2148 | L-731735 | Lipiferolide | Pepticinnamin E
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)